These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 35117874)

  • 1. Stereotactic body radiotherapy (SBRT) for oligo-metastatic liver metastases from breast cancer, as an effective and safe alternative to surgery: a review.
    Aoki S; Yamashita H; Abe O; Nakagawa K
    Transl Cancer Res; 2020 Aug; 9(8):5087-5095. PubMed ID: 35117874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligometastases: history of a hypothesis.
    Milano MT; Biswas T; Simone CB; Lo SS
    Ann Palliat Med; 2021 May; 10(5):5923-5930. PubMed ID: 32279519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment outcomes of breast cancer liver metastasis treated with stereotactic body radiotherapy.
    Onal C; Guler OC; Yildirim BA
    Breast; 2018 Dec; 42():150-156. PubMed ID: 30296648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modern evidence and future prospects of external body radiation therapy for lung oligometastases of breast cancer.
    Wada Y; Hashimoto M
    Transl Cancer Res; 2020 Aug; 9(8):5077-5086. PubMed ID: 35117873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
    Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
    Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS).
    Thureau S; Marchesi V; Vieillard MH; Perrier L; Lisbona A; Leheurteur M; Tredaniel J; Culine S; Dubray B; Bonnet N; Asselain B; Salleron J; Faivre JC
    BMC Cancer; 2021 Feb; 21(1):117. PubMed ID: 33541288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Options in Oligometastatic Disease: Stereotactic Body Radiation Therapy - Focus on Colorectal Cancer.
    Wild AT; Yamada Y
    Visc Med; 2017 Mar; 33(1):54-61. PubMed ID: 28612018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?
    Marvaso G; Corrao G; Oneta O; Pepa M; Zaffaroni M; Corso F; Gandini S; Cecconi A; Zerini D; Mazzola GC; Augugliaro M; Cossu Rocca M; Verri E; Cattani F; La Fauci F; Bergamaschi L; Luzzago S; Mistretta AF; Musi G; Nolè F; De Cobelli O; Orecchia R; Jereczek-Fossa BA
    Clin Transl Oncol; 2021 Aug; 23(8):1717-1726. PubMed ID: 33687659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic body radiation therapy for liver metastases.
    Scorsetti M; Clerici E; Comito T
    J Gastrointest Oncol; 2014 Jun; 5(3):190-7. PubMed ID: 24982767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic body radiotherapy using the CyberKnife
    Ihnát P; Skácelíková E; Tesař M; Penka I
    Onco Targets Ther; 2018; 11():4685-4691. PubMed ID: 30127616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local Treatment of Breast Cancer Liver Metastasis.
    Bale R; Putzer D; Schullian P
    Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31514362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up.
    Scorsetti M; Comito T; Clerici E; Franzese C; Tozzi A; Iftode C; Di Brina L; Navarria P; Mancosu P; Reggiori G; Fogliata A; Tomatis S; Torzilli G; Cozzi L
    Radiat Oncol; 2018 Nov; 13(1):234. PubMed ID: 30477560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study.
    Milano MT; Katz AW; Zhang H; Okunieff P
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):878-86. PubMed ID: 22172903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of stereotactic body radiotherapy in multidisciplinary management of liver metastases in patients with colorectal cancer.
    Sanuki N; Takeda A; Tsurugai Y; Eriguchi T
    Jpn J Radiol; 2022 Oct; 40(10):1009-1016. PubMed ID: 35857212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver SBRT with active motion-compensation results in excellent local control for liver oligometastases: An outcome analysis of a pooled multi-platform patient cohort.
    Stera S; Miebach G; Buergy D; Dreher C; Lohr F; Wurster S; Rödel C; Marcella S; Krug D; Frank A G; Ehmann M; Fleckenstein J; Blanck O; Boda-Heggemann J
    Radiother Oncol; 2021 May; 158():230-236. PubMed ID: 33667585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic Body Radiotherapy (SBRT) for liver metastasis - clinical outcomes from the international multi-institutional RSSearch® Patient Registry.
    Mahadevan A; Blanck O; Lanciano R; Peddada A; Sundararaman S; D'Ambrosio D; Sharma S; Perry D; Kolker J; Davis J
    Radiat Oncol; 2018 Feb; 13(1):26. PubMed ID: 29439707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SBRT for lung oligometastases: Who is the perfect candidate?
    Navarria P; De Rose F; Ascolese AM
    Rep Pract Oncol Radiother; 2015; 20(6):446-53. PubMed ID: 26696785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligometastatic breast cancer: where are we now and where are we headed?-a narrative review.
    Kent CL; McDuff SGR; Salama JK
    Ann Palliat Med; 2021 May; 10(5):5954-5968. PubMed ID: 32921069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence.
    Nakamura M; Hashimoto N; Mayahara H; Uezono H; Harada A; Nishikawa R; Matsuo Y; Kawaguchi H; Nishimura H
    Radiat Oncol; 2018 Apr; 13(1):75. PubMed ID: 29688858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical applications of stereotactic radiation therapy for oligometastatic cancer patients: a disease-oriented approach.
    Ricardi U; Badellino S; Filippi AR
    J Radiat Res; 2016 Aug; 57(S1):i58-i68. PubMed ID: 26962198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.